Top Markets
#1 Arowana Arowana +40.15%
#2 Tutorial Tutorial +33.39%
#3 Fabric Protocol Fabric Protocol +31.03%
#4 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +28.74%
#5 Bitcoin Cash Bitcoin Cash +28.40%
#6 Ethena Staked ENA Ethena Staked ENA +26.40%
#7 The Black Bull The Black Bull +25.66%
#8 Audiera Audiera +25.51%
#9 Zora Zora +25.16%
#10 GALA GALA +23.86%
Coin of the day
Arowana Arowana
Settings
Language
ENGLISH
Currency
USD
Theme
K Pharma,Inc. K Pharma,Inc.

K Pharma,Inc.

4896
Rank in Stocks #24700
K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and... K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.
Share Price
$4.97
Market Cap
$57.71M
Change (1 day)
-2.06%
Change (1 year)
7.52%
Country
JP
Trade K Pharma,Inc. (4896)

Category

Healthcare
Revenue for K Pharma,Inc. (4896)
Revenue in Aug 2026 TTM: 0
According to K Pharma,Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for K Pharma,Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH